1
|
Kalishwaralal K, Azeez Nazeer A, Induja DK, Keerthana CK, Shifana SC, Anto RJ. Enhanced extracellular vesicles mediated uttroside B (Utt-B) delivery to Hepatocellular carcinoma cell: Pharmacokinetics based on PBPK modelling. Biochem Biophys Res Commun 2024; 703:149648. [PMID: 38368675 DOI: 10.1016/j.bbrc.2024.149648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2024] [Revised: 01/26/2024] [Accepted: 02/06/2024] [Indexed: 02/20/2024]
Abstract
Our prior investigation has confirmed that the anti-hepatocellular carcinoma activity of the plant saponin, specifically Uttroside B (Utt-B), derived from the leaves of Solanum nigrum Linn. This study concentrated on formulating a novel biocompatible nanocarrier utilizing Extracellular vesicles (EVs) to enhance the delivery of plant saponin into cells. The physicochemical attributes of Extracellular Vesicles/UttrosideB (EVs/Utt-B) were comprehensively characterized through techniques such as Transmission Electron Microscopy (TEM) and Fourier-transform infrared spectroscopy (FTIR). Despite the promising therapeutic potential of this uttroside B, mechanistic know-how about its entry into cells is still in its infancy. Our research sheds light on the extracellular vesicle-mediated mechanism facilitating the entry of the saponin into cells, a phenomenon confirmed through the use of by confocal microscopy. We further analysed drug-releasing kinetics and simulated the Pharmacokinetics by PBPK modelling. The simulated pharmacokinetics revealed the bioavailability of Uttroside-B in oral administration against intravenous administration.
Collapse
Affiliation(s)
- Kalimuthu Kalishwaralal
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, 95014, Kerala, India.
| | - Abdul Azeez Nazeer
- Laboratory of Pharmaceutical Sciences, College of Pharmacy, Kangwon National University, Chuncheon, Gangwon state, 24341, Republic of Korea
| | - D K Induja
- Chemical Sciences and Technology Division, CSIR-National Institute for Interdisciplinary Science and Technology (CSIR-NIIST), Thiruvananthapuram, 695019, Kerala, India
| | - Chenicheri K Keerthana
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, 95014, Kerala, India
| | - Sadiq C Shifana
- Molecular Bioassay Laboratory, Institute of Advanced Virology, Thiruvananthapuram, 695317, Kerala, India
| | - Ruby John Anto
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, 95014, Kerala, India; Molecular Bioassay Laboratory, Institute of Advanced Virology, Thiruvananthapuram, 695317, Kerala, India
| |
Collapse
|
2
|
Mahdieh A, Motasadizadeh H, Maghsoudian S, Sabzevari A, Khalili F, Yeganeh H, Nyström B. Novel polyurethane-based ionene nanoparticles electrostatically stabilized with hyaluronic acid for effective gene therapy. Colloids Surf B Biointerfaces 2024; 236:113802. [PMID: 38382225 DOI: 10.1016/j.colsurfb.2024.113802] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2023] [Revised: 01/29/2024] [Accepted: 02/13/2024] [Indexed: 02/23/2024]
Abstract
Gene therapy is considered to be a valuable strategy for effective cancer treatment. However, the development of effective delivery systems that can specifically deliver gene materials, such as siRNA to tumor tissues plays a critical role in cancer therapy. In the present study, we have developed a novel complex that is based on an electrostatic interaction between cationic polyurethane ionene (CPUI) nanoparticles and an anti-signal transducer and activator of transcription 3 (STAT3) siRNA. For active targeting, hyaluronic acid (HA) was used to coat the complexes, which significantly reduced the cytotoxicity of the blank nanocarriers while demonstrating high transport efficiency of the siRNA via the CD44-mediated endocytosis pathway in MCF-7 breast cancer cells. The targeted nanocarriers (HA/CPUI/siRNA) showed significantly higher cellular internalization in flow cytometry and confocal microscopy compared with the non-targeted system (CPUI/siRNA). In addition, the incorporation of HA on the surface of the complexes resulted in significantly greater suppression of the STAT3 gene compared to the corresponding non-targeted formulation. Whole-body fluorescence images showed more significant tumor accumulation of the targeted nanocarriers in 4T1 breast tumor-bearing mice. Therefore, HA/CPUI/siRNA nanocarriers are an interesting option for the siRNA-targeted treatment of breast cancer cells.
Collapse
Affiliation(s)
- Athar Mahdieh
- Department of Pharmacy, Section for Pharmaceutics and Social Pharmacy, University of Oslo, Oslo, Norway
| | - Hamidreza Motasadizadeh
- Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran
| | - Samane Maghsoudian
- Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | - Alireza Sabzevari
- Polymer Faculty, Biomedical Engineering Department, Meybod University, Meybod, Yazd, Iran; Polymer Engineering Department, Faculty of Chemical Engineering, Tarbiat Modares University, Tehran, Iran
| | - Fereshte Khalili
- Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | - Hamid Yeganeh
- Iran Polymer and Petrochemical Institute, Tehran, Iran
| | - Bo Nyström
- Department of Chemistry, University of Oslo, Oslo, Norway.
| |
Collapse
|
3
|
Jasim A, Albukhaty S, Sulaiman GM, Al-Karagoly H, Jabir MS, Abomughayedh AM, Mohammed HA, Abomughaid MM. Liposome Nanocarriers Based on γ Oryzanol: Preparation, Characterization, and In Vivo Assessment of Toxicity and Antioxidant Activity. ACS Omega 2024; 9:3554-3564. [PMID: 38284009 PMCID: PMC10809378 DOI: 10.1021/acsomega.3c07339] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/23/2023] [Revised: 12/09/2023] [Accepted: 12/25/2023] [Indexed: 01/30/2024]
Abstract
The present study aimed to develop and characterize liposome nanocarriers based on γ oryzanol and evaluate their potential in vitro and in vivo toxicity and antioxidant effects. The liposomes were physicochemically characterized using various techniques, including dynamic light scattering (DLS) for size and polydispersity index (PDI) measurements and ζ-potential analysis. The in vitro toxicity assessments were performed using hemolysis and MTT assays on the HS5 cell line. In vivo, acute oral toxicity was evaluated by using LD50 assays in mice. Additionally, antioxidant activity was assessed through biochemical analysis of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels and liver tissue catalase, malondialdehyde (MDA), and glutathione (GSH) levels. The results revealed that the liposomes exhibited a uniform and spherical morphology with suitable physicochemical properties for drug delivery applications. The in vitro cytotoxicity and hemolysis assays and the in vivo LD50 experiment indicated the potential safety of γ oryzanol liposomes, especially at lower concentrations. In addition, the assessment of liver enzymes, i.e., ALT and AST, and the antioxidant markers further revealed the safety of the formulation, particularly for the liver as a highly sensitive soft organ. Overall, the liposome nanocarriers based on γ oryzanol were successfully formulated and expressed potential safety, supporting their application for the purposes of drug delivery and therapeutic interventions, particularly for hepatocellular and antioxidant therapies; however, further investigations for preclinical and clinical studies could be the future prospects for liposome nanocarriers based on γ oryzanol to explore the safety and efficacy of these nanocarriers in various disease models and clinical settings.
Collapse
Affiliation(s)
- Ahmed
J. Jasim
- Department
of Biomedical Engineering, University of
Technology, Baghdad 10066, Iraq
| | - Salim Albukhaty
- Department
of Chemistry, College of Science, University
of Misan, Maysan 62001, Iraq
- College
of Medicine, University of Warith Al-Anbiyaa, Karbala 56001, Iraq
| | - Ghassan M. Sulaiman
- Division
of Biotechnology, Department of Applied Sciences, University of Technology, Baghdad 10066, Iraq
| | - Hassan Al-Karagoly
- Department
of Internal and Preventive Medicine, College of Veterinary Medicine, University of Al-Qadisiyah, Al-Diwaniyah 58001, Iraq
| | - Majid S. Jabir
- Division
of Biotechnology, Department of Applied Sciences, University of Technology, Baghdad 10066, Iraq
| | - Ali M. Abomughayedh
- Pharmacy
Department, Aseer Central Hospital, Ministry
of Health, Asir 62523, Saudi Arabia
| | - Hamdoon A. Mohammed
- Department
of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Qassim 51452, Saudi Arabia
- Department
of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy, Al-Azhar University, Cairo 11371, Egypt
| | - Mosleh M. Abomughaid
- Department
of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, 255, Al Nakhil, Bisha 67714, Saudi Arabia
| |
Collapse
|
4
|
Mahdieh A, Yeganeh H, Motasadizadeh H, Nekoueifard E, Maghsoudian S, Hossein Ghahremani M, Nyström B, Dinarvand R. Waterborne polyurethane magnetic nanomicelles with magnetically governed functions for breast cancer therapy. Int J Pharm 2023; 645:123356. [PMID: 37661033 DOI: 10.1016/j.ijpharm.2023.123356] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2023] [Revised: 08/22/2023] [Accepted: 08/26/2023] [Indexed: 09/05/2023]
Abstract
Drug delivery strategies aim to maximize a drug's therapeutic efficiency by increasing the drug's concentration at the target site while minimizing delivery to off-target tissues. There is a great deal of interest in using magnetic nanoparticles in combination with applied magnetic fields to selectively control drug accumulation and release in target tissue while minimizing effects on other tissues. In this study, a magnetic targeted drug delivery system based on waterborne polyurethane nanomicelles was prepared by encapsulating hydrophobic doxorubicin (DOX, model drug) and hydrophobic oleic acid-superparamagnetic nanoparticles (SPION-OA) into the hydrophobic core of waterborne polyurethane micelles (CPUM) using the solvent evaporation method. The prepared drug-loaded magnetomicelles (CPUM-DOX-SPION) had a spherical shape with an average diameter of 158 nm. The magnetomicelles showed superparamagnetic properties with excellent magnetic resonance imaging (MRI) contrast effects and T2 relaxation in vitro. In the absence and presence of a magnetic field, the cytocompatibility and cellular uptake of the samples were assessed by MTT assay and flow cytometry, respectively, and the cells were imaged with a confocal microscope. Application of the magnetic field increased cellular cytotoxicity and cellular uptake in association with improved DOX delivery. In addition, the in vivo study of tumor volume showed that tumor growth of the mice group treated with CPUM-DOX-SPION in the presence of an external magnetic field was significantly retarded, with no apparent loss of body weight, compared with the same magnetomicelles in the absence of the magnetic field and with free DOX at the same dose. Moreover, the in vivo MRI experiment indicated the potential of these magnetomicelles as a probe in MRI diagnosis for tumor targeting, and the results showed that magnetically guided delivery of CPUM-SPION magnetomicelles into tumors could significantly improve the targeting efficacy. All the results suggest that the prepared novel magnetomicelles will be promising theranostic systems for effective magnetically guided delivery of chemotherapeutic agents and image-guided personalized medicine.
Collapse
Affiliation(s)
- Athar Mahdieh
- Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 14174, Iran; Department of Pharmacy, Section for Pharmaceutics and Social Pharmacy, University of Oslo, N-0316, Oslo, Norway
| | - Hamid Yeganeh
- Iran Polymer and Petrochemical Institute, P.O. Box: 14965-115, Tehran, Iran.
| | - Hamidreza Motasadizadeh
- Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 14174, Iran; Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 14174, Iran
| | - Effat Nekoueifard
- Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 14174, Iran; Department of Cell Engineering, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
| | - Samane Maghsoudian
- Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 14174, Iran; Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 14174, Iran
| | - Mohammad Hossein Ghahremani
- Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | - Bo Nyström
- Department of Chemistry, University of Oslo, P.O. Box 1033, Blindern N-0315, Oslo, Norway
| | - Rassoul Dinarvand
- Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 14174, Iran; Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 14174, Iran; Leicester School of Pharmacy, De Montfort University, Leicester, United Kingdom.
| |
Collapse
|
5
|
Mahdieh A, Yeganeh H, Sande SA, Nyström B. Design of novel polyurethane-based ionene nanocarriers for cancer therapy: Synthesis, in-vitro, and in-vivo studies. Int J Pharm 2023; 635:122768. [PMID: 36841369 DOI: 10.1016/j.ijpharm.2023.122768] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2022] [Revised: 02/01/2023] [Accepted: 02/19/2023] [Indexed: 02/26/2023]
Abstract
New strategies for constructing versatile nanocarriers are needed for cancer therapy to overcome the multiple challenges of targeted delivery. This work explores the advantages of polyurethane with main-chain quaternary ammonium salt moieties (ionene) as a novel carrier for targeted drug delivery. We have developed a novel cationic soybean oil-based polyurethane ionene nanocarrier (CPUI) that can act as an effective anticancer agent and efficiently deliver the anticancer drug 5-fluorouracil (5FU). We also report a potential anticancer drug delivery system targeting the folate receptor. In vitro experiments with blank CPUI carriers on the 4T1 (mouse breast cancer cell line) and the NIH-3T3 (mouse fibroblast cell line) revealed high cytotoxicity for the cancer cells but only low cytotoxicity for the normal fibroblast cells. The CPUI nanoparticles were readily loaded with 5FU (5FU-CPUI) in water using electrostatic interactions between the cationic quaternary ammonium groups of ionene and the anionic 5FU. The in vivo study in mice with tumors showed that the blank CPUI carriers significantly inhibited tumor growth, even more than the free drug (5FU). The inhibitory effect on tumor growth was slightly enhanced when the carriers were loaded with 5FU. The prepared nanoparticles had a high loading capacity of 41.8 %. Further enhancement of the inhibitory effect was observed when folic acid (FA) was added as a targeting moiety to the system via ion exchange with the bromine counterion of the quaternary ammonium moieties. The results suggest that the efficacy of FA-CPUI-5FU nanoparticles as vehicles for drug delivery can be enhanced via folate receptor (FR) mediated endocytosis in 4T1 cells and these novel nanocarriers may provide a potential platform for effective targeted drug delivery to tumor tissue and breast cancer therapy in the clinic.
Collapse
Affiliation(s)
- Athar Mahdieh
- Department of Pharmacy, Section for Pharmaceutics and Social Pharmacy, University of Oslo, Oslo, Norway
| | - Hamid Yeganeh
- Iran Polymer and Petrochemical Institute, Tehran, Iran.
| | - Sverre Arne Sande
- Department of Pharmacy, Section for Pharmaceutics and Social Pharmacy, University of Oslo, Oslo, Norway
| | - Bo Nyström
- Department of Chemistry, University of Oslo, Oslo, Norway.
| |
Collapse
|
6
|
Santos Y, Costa G, Menezes J, Feitosa A, Coutinho H, Sena D, Filho F, Teixeira R. Pb(II) Ion Removal Potential in Chemically Modified Ziziphus joazeiro Barks. Int J Environ Res Public Health 2022; 19:16283. [PMID: 36498352 PMCID: PMC9736088 DOI: 10.3390/ijerph192316283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/02/2022] [Revised: 11/24/2022] [Accepted: 12/01/2022] [Indexed: 06/17/2023]
Abstract
In this study, five types of modified Ziziphus joazeiro barks were investigated for the removal of Pb(II) ions from aqueous solutions. The samples tested were natural barks, natural powder, washed with water, ethanol at 80% (EE) and 0.5 N NaOH. Batch kinetics experiments were performed under the conditions: 24−25 °C, pH 5.5−5.8, 102 mg·L−1 Pb(NO3)2, 100 rpm and 0.1 g of adsorbent, and analyses of pHpzc and Fourier transform infrared spectroscopy. All adsorbents tested showed potential to remove Pb(II) ions, but the adsorbent washed by 0.5 N NaOH obtained the highest experimental performance (25.5 mg·g−1 at 30 min), while the EE had the least performance (20.4 mg·g−1 at 60 min), and maximum removals of 99.9%. The kinetic models pointed to a probable chemisorption due to the best fit of pseudo-second order and Elovich, and Boyd’s model, suggesting that intraparticle diffusion limits the adsorption until the initial minutes of contact. The Langmuir isotherm fitted better to the experimental data for the NaOH adsorbent, with maximum adsorption capacity equal to 62.5 mg·g−1, although the Temkin model partially fitted, both suggesting the occurrence of chemisorption. The adsorption process is reversible (>81% at 20 min) and hence the adsorbents can be recycled and the Pb(II) ions recovered.
Collapse
Affiliation(s)
- Yannice Santos
- Environmental and Sanitary Engineering Course, Federal Institute of Education, Science and Technology—Campus Juazeiro do Norte, Juazeiro do Norte 63048-080, Brazil
- Department of Biological Chemistry, Regional University of Cariri, Crato 63105-010, Brazil
| | - Gilvânia Costa
- Environmental and Sanitary Engineering Course, Federal Institute of Education, Science and Technology—Campus Juazeiro do Norte, Juazeiro do Norte 63048-080, Brazil
| | - Jorge Menezes
- Science and Technology Center, Federal University of Cariri, Juazeiro do Norte 63048-080, Brazil
| | - Alex Feitosa
- Department of Biological Chemistry, Regional University of Cariri, Crato 63105-010, Brazil
| | - Henrique Coutinho
- Department of Biological Chemistry, Regional University of Cariri, Crato 63105-010, Brazil
| | - Diniz Sena
- Department of Biological Chemistry, Regional University of Cariri, Crato 63105-010, Brazil
| | - Francisco Filho
- Science and Technology Center, Federal University of Cariri, Juazeiro do Norte 63048-080, Brazil
| | - Raimundo Teixeira
- Department of Biological Chemistry, Regional University of Cariri, Crato 63105-010, Brazil
| |
Collapse
|
7
|
Mahdieh A, Motasadizadeh H, Yeganeh H, Nyström B, Dinarvand R. Redox-responsive waterborne polyurethane nanocarriers for targeted doxorubicin delivery. Int J Pharm 2022; 628:122275. [DOI: 10.1016/j.ijpharm.2022.122275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2022] [Revised: 09/20/2022] [Accepted: 10/05/2022] [Indexed: 11/19/2022]
|
8
|
Honarmandpour A, Fatahinia M, Masoud Keshavarzzade A, Namjoyan F, Maraghi E, Kamali H. The effects of Ziziphus Spina leaves’ Hydro-Alcoholic Extract Vaginal Cream and Clotrimazole on Candida albicans in Wistar Rats. Clin Med�Insights�Pathol 2022; 15:2632010X221138664. [PMID: 36438542 PMCID: PMC9685217 DOI: 10.1177/2632010x221138664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/31/2022] [Accepted: 10/27/2022] [Indexed: 11/22/2022]
Abstract
Background: In vitro, Ziziphus Spina-Christi (ZSC) leaves have been shown to have
antimicrobial and antifungal effects. This study aimed to
examine the effects of Ziziphus Spina leaves hydro-alcoholic extracts with
Clotrimazole against Candida albicans in female rats. Methods: Four groups of rats were infected vaginally with C.
Albicans, and 1 group not infected was considered negative control. The
infected groups received the following treatments: 2 groups were treated
with vaginal 5%, or 10%, of Ziziphus Spina extract creams. One group
received 1% clotrimazole, and 1 group did not receive any treatment
considered a positive control. Results: The mean number of colony-forming units (CFUs) before the intervention was
195.83 ± 395.126 in the 5% ZSC group, 346.33 ± 396.719 in the 10% ZSC group,
345.17 ± 507.431 in the clotrimazole group, 212.20 ± 148.304 in the positive
control group (P = .604), and 0 in the negative control
group (P = .003). After 1 week, the average number of CFUs
considerably dropped to 65.14 ± 36.03 in the 5% ZSC group, 1.43 ± 3.60 in
the 10% ZSC group, and 0.43 ± 1.13 in the clotrimazole group. The number in
the positive control group remained unchanged (212.20 ± 148.304)
(P = .005). After 2 weeks, the average number of CFUs
was 0 in the 10% ZSC group, Clotrimazole and negative control groups and was
4.57 ± 23.99 in the 5% ZSC group (P < .001). Conclusions: Our findings indicated that the effectiveness of Vaginal creams containing
10% Ziziphus Spina is similar to Clotrimazole in eliminating
C. Albicans.
Collapse
Affiliation(s)
- Azam Honarmandpour
- Department of Midwifery, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran
| | - Mahnaz Fatahinia
- Department of Medical Mycology, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
| | | | - Forogh Namjoyan
- Pharmacognosy Department, Marine natural Pharmaceutical Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
| | - Elham Maraghi
- Department of Biostatistics and Epidemiology Faculty of Public Health, Ahvaz Jundishapur University of Medical Sciences Ahvaz, Iran
| | - Hossein Kamali
- MSc of Anatomy, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran
| |
Collapse
|